PERSPECTA

News from every angle

Back to headlines

Bio-Techne Stock Surges on Merck KGaA Acquisition Offer

Bio-Techne's stock experienced a significant surge after Merck KGaA announced a cash acquisition offer of $73 per share, signaling a major development in the biotechnology sector.

25 Jun, 21:43 — 25 Jun, 21:43
PostShare

Sources

Showing 1 of 1 sources